dr. vogelzang discusses the cabozantinib trial design
Published 13 years ago • 238 plays • Length 1:34Download video MP4
Download video MP3
Similar videos
-
1:35
dr. vogelzang discusses cabozantinib trial design
-
1:36
dr. vogelzang discusses mortalities in cabozantinib trial
-
1:45
dr. vogelzang discusses cabozantinib's dose size
-
0:56
dr. vogelzang on cabozantinib clinical trial results
-
1:14
dr. vogelzang describes cabozantinib's side effects
-
10:01
undergoing treatment: cabozantinib toxicity management
-
11:13
for patients: how cabometyx® (cabozantinib) may work
-
1:06:44
pasquale d'acunzo and efrat levy: mitochondrial-origin extracellular vesicles in down syndrome
-
0:59
dr. ezra cohen discusses the cabozantinib exam trial
-
1:11
dr. vogelzang on xl184's effect on bone metastases
-
1:34
dr. vogelzang discusses prospect trial for prostate cancer
-
2:22
nicholas vogelzang, md, discusses re-emergence of dose reduced cabozantinib alezotuzumab in apc
-
1:16
dr. ezra cohen discusses the cabozantinib dose size and tolerability
-
1:27
dr. ezra cohen on the efficacy and pharmacokinetics of cabozantinib
-
1:04
nicholas j. vogelzang, md, discusses the difference in mortality in the prosper and spartan trials
-
1:19
dr. nicholas vogelzang on first-line axitinib versus sorafenib in mrcc
-
1:53
dr. nicholas vogelzang discusses sequencing abiraterone and enzalutamide
-
1:12
dr. vogelzang discusses mpdl3280a in patients with metastatic urothelial bladder cancer
-
1:34
dr. eric sherman on the sequencing of cabozantinib and vandetanib for mtc
-
0:57
dr. tolaney on trials investigating cabozantinib in breast cancer
-
1:22
dr. grigg discusses cabosun trial in mrcc
-
1:19
dr. agarwal on the safety of cabozantinib/atezolizumab in mcrpc